As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including AMN Healthcare Services (NYSE:AMN) and its peers.
Let’s dig into the relative performance of agilon health (NYSE:AGL) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnings season.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare providers & services stocks, including McKesson (NYSE:MCK) and its peers.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Cardinal Health (NYSE:CAH) and the best and worst performers in the healthcare providers & services industry.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including Pediatrix Medical Group (NYSE:MD) and its peers.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare providers & services industry, including The Ensign Group (NASDAQ:ENSG) and its peers.
Looking back on outpatient & specialty care stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including U.S. Physical Therapy (NYSE:USPH) and its peers.
Growth is oxygen.
But when it evaporates, the consequences can be extreme - ask anyone who bought Cisco in the Dot-Com Bubble (Nvidia?) or newer investors who lived through the 2020 to 2022 COVID cycle.
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Healthcare services company Agilon Health (NYSE:AGL) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 44.2% year on year to $1.52 billion. On the other hand, next quarter’s revenue guidance of $1.5 billion was less impressive, coming in 12% below analysts’ estimates. Its GAAP loss of $0.26 per share was 14.8% below analysts’ consensus estimates.
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
